PubRank

Claude Sirlin

Author PubWeight™ 28.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ru-, Rh-, and Pd-catalyzed C-C bond formation involving C-H activation and addition on unsaturated substrates: reactions and mechanistic aspects. Chem Rev 2002 2.71
2 Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology 2014 2.00
3 Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr 2006 1.97
4 Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology 2012 1.89
5 Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 2013 1.78
6 CT evaluation of appendicitis and its complications: imaging techniques and key diagnostic findings. AJR Am J Roentgenol 2005 1.62
7 Association of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal Aortic Calcium Study. Am J Epidemiol 2008 1.45
8 ISMRM workshop on fat-water separation: insights, applications and progress in MRI. Magn Reson Med 2012 1.35
9 Assessment of liver fat quantification in the presence of iron. Magn Reson Imaging 2010 1.30
10 Abdominal wall hernias: MDCT findings. AJR Am J Roentgenol 2004 1.17
11 Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist. Proc Natl Acad Sci U S A 2012 1.16
12 Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging. J Magn Reson Imaging 2012 1.06
13 A ruthenium-containing organometallic compound reduces tumor growth through induction of the endoplasmic reticulum stress gene CHOP. Cancer Res 2009 1.06
14 Bone mineral density and atherosclerosis: the Multi-Ethnic Study of Atherosclerosis, Abdominal Aortic Calcium Study. Atherosclerosis 2009 1.03
15 Delayed traumatic bladder rupture. AJR Am J Roentgenol 2005 1.00
16 Induction of caspase 8 and reactive oxygen species by ruthenium-derived anticancer compounds with improved water solubility and cytotoxicity. Biochem Pharmacol 2012 0.91
17 Library of second-generation cycloruthenated compounds and evaluation of their biological properties as potential anticancer drugs: passing the nanomolar barrier. Dalton Trans 2011 0.85
18 Superparamagnetic iron oxides and low molecular weight gadolinium chelates are synergistic for direct visualization of advanced liver fibrosis. J Magn Reson Imaging 2007 0.85
19 DNA binding to an anticancer organo-ruthenium complex. J Phys Chem B 2010 0.84
20 Error model for reduction of cardiac and respiratory motion effects in quantitative liver DW-MRI. Magn Reson Med 2012 0.83
21 Acute appendicitis: diagnostic value of nonenhanced CT with selective use of contrast in routine clinical settings. Eur Radiol 2006 0.83
22 Apparent diffusion coefficient of fibrosis and regenerative nodules in the cirrhotic liver at MRI. AJR Am J Roentgenol 2010 0.82
23 Recognition of chiral carboxylic anions by artificial receptors. Int J Mol Sci 2010 0.79
24 Cycloruthenated primary and secondary amines as efficient catalyst precursors for asymmetric transfer hydrogenation. Org Lett 2005 0.76
25 Synthesis, characterization, and electrochemistry of biorelevant photosensitive low-potential orthometalated ruthenium complexes. Inorg Chem 2005 0.75
26 Transient homogeneously enhancing hepatic masses: can size predict benignity? AJR Am J Roentgenol 2008 0.75